What is the significance of WIPO Standard ST.26 in the MPEP’s definition of nucleotides?

The MPEP 2412.03(d) explicitly references WIPO Standard ST.26 in its definition of nucleotides: “‘Nucleotide’ includes any nucleotide, nucleotide analog, or modified nucleotide as defined in paragraphs 3(f) and 3(g) of WIPO Standard ST.26.” WIPO Standard ST.26 is an international standard for the presentation of nucleotide and amino acid sequence listings in patent applications. Its incorporation…

Read More

What is the definition of “nucleotide” according to the MPEP?

According to MPEP 2412.03(d), a “nucleotide” is defined as follows: “‘Nucleotide’ includes any nucleotide, nucleotide analog, or modified nucleotide as defined in paragraphs 3(f) and 3(g) of WIPO Standard ST.26.” This definition encompasses a wide range of nucleotide structures, including both natural and modified forms. The MPEP further elaborates that a nucleotide contains: A specific…

Read More

What types of backbone moieties are included in the MPEP’s definition of a nucleotide?

The MPEP 2412.03(d) provides a comprehensive list of backbone moieties that can be part of a nucleotide. These include: 2′ deoxyribose 5′ monophosphate (found in deoxyribonucleotides) Ribose 5′ monophosphate (found in ribonucleotides) Analogues of the above that mimic the nucleobase arrangement and allow base pairing The MPEP also provides examples of alternative backbone moieties: “examples…

Read More

How does the MPEP address nucleotide analogs in its definition?

The MPEP 2412.03(d) includes nucleotide analogs in its comprehensive definition of nucleotides. Specifically, it states: “‘Nucleotide’ includes any nucleotide, nucleotide analog, or modified nucleotide as defined in paragraphs 3(f) and 3(g) of WIPO Standard ST.26.” The MPEP further elaborates on nucleotide analogs by describing backbone moieties that can be part of these structures: “an analogue…

Read More